Oral contraceptives, venous thrombosis, and varicose veins. Royal College of General Practitioners' Oral Contraception Study
- PMID: 702453
- PMCID: PMC2158790
Oral contraceptives, venous thrombosis, and varicose veins. Royal College of General Practitioners' Oral Contraception Study
Abstract
PIP: To refine 1974 results on venous thrombosis and oral contraceptives (OCs) from a prospective study begun in 1968 comparing 23,000 women using OCs with 23,000 controls, women with known preexisting conditions relevant to thrombosis were excluded. Rates in each contraceptive category (users, ex-users, and controls) were indirectly standardized for age, parity, cigarette consumption, and social class. The relative risk (users to nonusers) of deep vein thrombosis was 4.17; for superficial vein thrombosis, it was 2.41. For other thrombosis and pulmonary embolism, trends were similar but the differences were not significant. Rates of ex-users did not differ significantly from the controls, implying no persistent risk after OC use ends. Superficial thrombosis correlated significantly with age, parity, and estrogen dose and progesterone content of OCs, but deep vein thrombosis did not. The risk of superficial thrombosis was significantly increased in users and nonusers with severe varicose veins, and increased with the severity; no significant relationship was found with deep vein thrombosis.
Similar articles
-
Population-based study of risk of venous thromboembolism associated with various oral contraceptives.Lancet. 1997 Jan 11;349(9045):83-8. doi: 10.1016/s0140-6736(96)07496-x. Lancet. 1997. PMID: 8996419
-
First-time use of newer oral contraceptives and the risk of venous thromboembolism.Contraception. 1997 Sep;56(3):141-6. doi: 10.1016/s0010-7824(97)00119-4. Contraception. 1997. PMID: 9347203
-
The Royal College of General Practitioners' Oral Contraception Study: some recent observations.Clin Obstet Gynaecol. 1984 Dec;11(3):759-86. Clin Obstet Gynaecol. 1984. PMID: 6509858
-
Factor V Leiden: should we screen oral contraceptive users and pregnant women?BMJ. 1996 Nov 2;313(7065):1127-30. doi: 10.1136/bmj.313.7065.1127. BMJ. 1996. PMID: 8916702 Free PMC article. Review.
-
Cardiovascular effects of oral contraceptives: a review.Int J Fertil. 1989;34 Suppl:40-9. Int J Fertil. 1989. PMID: 2576258 Review.
Cited by
-
[The antibaby pill as a risk factor for thrombosis: are the molecular mechanisms known?].Klin Wochenschr. 1991 May 24;69(8):335-9. doi: 10.1007/BF02115778. Klin Wochenschr. 1991. PMID: 1886397 Review. German.
-
Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.Drugs. 2000 Oct;60(4):721-869. doi: 10.2165/00003495-200060040-00003. Drugs. 2000. PMID: 11085198 Review.
-
Evaluation of a prescription based record-linkage model for epidemiological studies of long-term adverse effects of drugs--with special regard to combined oral contraceptives.Eur J Clin Pharmacol. 1991;40(5):489-93. doi: 10.1007/BF00315228. Eur J Clin Pharmacol. 1991. PMID: 1884723
-
Combined oral contraceptives: venous thrombosis.Cochrane Database Syst Rev. 2014 Mar 3;2014(3):CD010813. doi: 10.1002/14651858.CD010813.pub2. Cochrane Database Syst Rev. 2014. PMID: 24590565 Free PMC article.
-
Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis.Drug Saf. 2012 Mar 1;35(3):191-205. doi: 10.2165/11598050-000000000-00000. Drug Saf. 2012. PMID: 22283630
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources